392 related articles for article (PubMed ID: 32412051)
21. LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases.
Pan J; Zhang D; Zhang J; Qin P; Wang J
Cancer Biol Ther; 2019; 20(5):653-665. PubMed ID: 30582709
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA SNHG16 regulates human aortic smooth muscle cell proliferation and migration via sponging miR-205 and modulating Smad2.
Lin Y; Tian G; Zhang H; Yuan W; Xie Y; Yang Y; Wang J; Liang Y
J Cell Mol Med; 2019 Oct; 23(10):6919-6929. PubMed ID: 31441592
[TBL] [Abstract][Full Text] [Related]
23. RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction.
Zhong J
Biol Chem; 2016 Mar; 397(3):215-22. PubMed ID: 26760308
[TBL] [Abstract][Full Text] [Related]
24. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
Yu X; Huang M; Yang G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
[TBL] [Abstract][Full Text] [Related]
25. LINC00839 Promotes Neuroblastoma Progression by Sponging miR-454-3p to Up-Regulate NEUROD1.
Zhang Q; Wei J; Li N; Liu B
Neurochem Res; 2022 Aug; 47(8):2278-2293. PubMed ID: 35606572
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of lncRNA SNHG16 inhibits vascular smooth muscle cell proliferation and migration in cerebral atherosclerosis by targeting the miR-30c-5p/SDC2 axis.
Yang SN; Zhong LY; Sun YH; Wang C; Ru WJ; Liu RZ; Dai W; Xie XM; Li SD
Heart Vessels; 2022 Jun; 37(6):1085-1096. PubMed ID: 35320391
[TBL] [Abstract][Full Text] [Related]
27. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells.
Liu P; Wilson MJ
J Cell Physiol; 2012 Feb; 227(2):867-76. PubMed ID: 21898400
[TBL] [Abstract][Full Text] [Related]
28. miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway.
Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
Biochem Biophys Res Commun; 2022 Sep; 619():76-83. PubMed ID: 35749939
[TBL] [Abstract][Full Text] [Related]
29. Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway.
Hou CH; Lin FL; Hou SM; Liu JF
Mol Cancer; 2014 Oct; 13():236. PubMed ID: 25326651
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of lncRNA SNHG16 on kidney clear cell carcinoma cells by targeting miR-506-3p/ETS1/RAS/ERK molecular axis.
Cheng T; Gu ML; Xu WQ; Ye DW; Zha ZY; Fang WG; Mao LK; Ning J; Hu XB; Ding YH
Heliyon; 2024 May; 10(9):e30388. PubMed ID: 38756581
[TBL] [Abstract][Full Text] [Related]
31. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
Zhou K; Luo X; Wang Y; Cao D; Sun G
Biomed Pharmacother; 2017 Sep; 93():1025-1032. PubMed ID: 28732393
[TBL] [Abstract][Full Text] [Related]
33. The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p/metalloproteinases 3 axis.
Peng H; Li H
Mol Carcinog; 2019 Aug; 58(8):1465-1480. PubMed ID: 31026378
[TBL] [Abstract][Full Text] [Related]
34. PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells.
Guo J; Lan Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):37-45. PubMed ID: 31852247
[No Abstract] [Full Text] [Related]
35. LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma.
Zhang N; Liu FL; Ma TS; Zhang ZZJ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8971-8983. PubMed ID: 31696485
[TBL] [Abstract][Full Text] [Related]
36. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
Wang X; Hu K; Chao Y; Wang L
Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
[TBL] [Abstract][Full Text] [Related]
37. Tax1 enhances cancer cell proliferation via Ras-Raf-MEK-ERK signaling pathway.
Song C; Wang W; Li M; Liu Y; Zheng D
IUBMB Life; 2009 Jun; 61(6):685-92. PubMed ID: 19472191
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p.
Li Y; Lu Y; Chen Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962265
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p.
Xiao X; Jiang G; Zhang S; Hu S; Fan Y; Li G; Yu H; He S
BMC Cancer; 2021 Apr; 21(1):355. PubMed ID: 33823834
[TBL] [Abstract][Full Text] [Related]
40. LncRNA double homeobox A pseudogene 8 (DUXAP8) facilitates the progression of neuroblastoma and activates Wnt/β-catenin pathway via microRNA-29/nucleolar protein 4 like (NOL4L) axis.
Nie L; Li C; Zhao T; Wang Y; Liu J
Brain Res; 2020 Nov; 1746():146947. PubMed ID: 32522628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]